FTC Challenges Terms of Watson Pharmaceuticals Acquisition of Andrx
Date
The Federal Trade Commission today announced its decision to challenge the terms of Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, a deal that would have led to...